Iceni Pharmaceuticals Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
Iceni Pharmaceuticals General Information
Description
Developer of a cancer drug intended to re-position and reformulate existing drugs for new disease indications. The company's therapies specialize in the development of a pentapeptide drug with a safety profile and a novel mechanism of action compared to existing myeloma treatments, enabling medical communities to reduce the risk, cost, and development time for treatments and maximize the chance of clinical success.
Contact Information
Website
www.icenipharma.comCorporate Office
- Wallace Building, Roslin Biocentre
- Midlothian
- Roslin EH25 9PP
- Scotland, United Kingdom
Corporate Office
- Wallace Building, Roslin Biocentre
- Midlothian
- Roslin EH25 9PP
- Scotland, United Kingdom
Iceni Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | 05-Sep-2023 | Completed | Out of Business | |||
| 8. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Mar-2016 | Completed | Generating Revenue | |||
| 6. Grant | 01-May-2014 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | 10-Dec-2012 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC | 09-Feb-2010 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 01-Nov-2008 | Completed | Clinical Trials - Phase 1 | |||
| 2. Grant | 01-Jan-2008 | $141K | $614K | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC | 01-Jan-2007 | $614K | $614K | Completed | Startup |
Iceni Pharmaceuticals Patents
Iceni Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3448408-A1 | Combination therapy | Inactive | 26-Apr-2016 | ||
| GB-2554333-A | Combination therapy | Inactive | 26-Apr-2016 | ||
| US-20190134148-A1 | Combination therapy | Inactive | 26-Apr-2016 | ||
| WO-2017187156-A1 | Combination therapy | Inactive | 26-Apr-2016 | ||
| GB-201506673-D0 | Combination therapy | Inactive | 20-Apr-2015 |
Iceni Pharmaceuticals Signals
Iceni Pharmaceuticals FAQs
-
When was Iceni Pharmaceuticals founded?
Iceni Pharmaceuticals was founded in 2006.
-
Where is Iceni Pharmaceuticals headquartered?
Iceni Pharmaceuticals is headquartered in Roslin, United Kingdom.
-
What is the size of Iceni Pharmaceuticals?
Iceni Pharmaceuticals has 3 total employees.
-
What industry is Iceni Pharmaceuticals in?
Iceni Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Iceni Pharmaceuticals a private or public company?
Iceni Pharmaceuticals is a Private company.
-
What is Iceni Pharmaceuticals’s current revenue?
The current revenue for Iceni Pharmaceuticals is .
-
How much funding has Iceni Pharmaceuticals raised over time?
Iceni Pharmaceuticals has raised $7.05M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process